Madison Dearborn's Ikaria to be acquired by Mallinckrodt

Mallinckrodt Plc said it would buy private equity-backed Ikaria Inc, a maker of a respiratory drug and its delivery system, for $2.3 billion to expand its reach in hospitals, Reuters reported.